Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Han Jo Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Display
Original Articles
Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer
Han Jo Kim, Moo-Jun Baek, Dong Hyun Kang, Sang-Cheol Lee, Sang Byung Bae, Kyu Taek Lee, Namsu Lee, Hyungjoo Kim, Dongjun Jeong, Tae Sung Ahn, Moon Soo Lee, Dae Sik Hong, Jong-Ho Won
Ann Coloproctol. 2018;34(2):88-93.   Published online April 30, 2018
DOI: https://doi.org/10.3393/ac.2017.10.10
  • 7,321 View
  • 118 Download
  • 5 Web of Science
  • 4 Citations
AbstractAbstract PDF
Purpose
Animal models show a strong relationship between lymphangiogenesis and lymph node metastasis. However, the clinical significance of lymphangiogenesis in patients with colorectal cancer (CRC) remains uncertain. This study aimed to evaluate the association between c-Met and lymphangiogenic factors and to elucidate the prognostic significance of c-Met in patients with CRC.
Methods
A total of 379 tissue samples were obtained from surgically resected specimens from patients with CRC at Soonchunhyang University Cheonan Hospital between January 2002 and December 2010. The expressions of c-Met, vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGF receptor (VEGFR)-3, and podoplanin were examined using immunohistochemistry. The expression of c-Met and clinical factors were analyzed.
Results
Of the 379 tissues, 301 (79.4%) had c-Met expression. High expression of c-Met in tumor cells was significantly associated with high expression of VEGF-C (P < 0.001) and VEGFR-3 (P = 0.001). However, no statistically significant association with podoplanin (P = 0.587) or VEGF-D (P = 0.096) was found. Of the 103 evaluable patients, expression of c-Met in tumor cells was significantly associated with advanced clinical stage (P = 0.020), positive lymph node status (P = 0.038), and high expression of VEGF-C (P = 0.020). However, no statistically significant association with podoplanin (P = 0.518), VEGFR-3 (P = 0.085), VEGF-D (P = 0.203), or overall survival (P = 0.360) was found.
Conclusion
Our results provide indirect evidence for an association and possible regulatory link of c-Met with the lymphangiogenic markers, but c-Met expression in patients with CRC is not a prognostic indicator for overall survival.

Citations

Citations to this article as recorded by  
  • Expression Profile of Microenvironmental Factors in the Interface Zone of Colorectal Cancer: Histological-Stromal Biomarkers and Cancer Cell-Cancer-Associated Fibroblast-Related Proteins Combined for the Assessment of Tumor Progression
    Ricella Souza da Silva, Eduardo M. Queiroga, Cynthia de Toledo Osório, Karin S. Cunha, Fabiana P. Neves, Julieth P. Andrade, Eliane P. Dias
    Pathobiology.2024; 91(2): 99.     CrossRef
  • Recent progress in the imaging of c‐Met aberrant cancers with positron emission tomography
    Giuseppe Floresta, Vincenzo Abbate
    Medicinal Research Reviews.2022; 42(4): 1588.     CrossRef
  • Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide
    María Belén Novoa Díaz, Pedro Carriere, Graciela Gigola, Ariel Osvaldo Zwenger, Natalia Calvo, Claudia Gentili
    World Journal of Gastroenterology.2022; 28(26): 3177.     CrossRef
  • The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancer
    Seyed Mostafa Parizadeh, Reza Jafarzadeh‐Esfehani, Danial Fazilat‐Panah, Seyed Mahdi Hassanian, Soodabeh Shahidsales, Majid Khazaei, Seyed Mohammad Reza Parizadeh, Majid Ghayour‐Mobarhan, Gordon A. Ferns, Amir Avan
    IUBMB Life.2019; 71(7): 802.     CrossRef
Expressions and Clinical Significances of Angiopoietin-1, Angiopoietin-2, and Tie-2 Receptor in Patients With Colorectal Cancer
Sunghoon Hong, Hae Il Jung, Tae Sung Ahn, Han-Jo Kim, Kyu-Taek Lee, Moo-Jun Baek, Sang-Byung Bae
Ann Coloproctol. 2017;33(1):9-15.   Published online February 28, 2017
DOI: https://doi.org/10.3393/ac.2017.33.1.9
  • 5,790 View
  • 55 Download
  • 17 Web of Science
  • 16 Citations
AbstractAbstract PDF
Purpose

Angiopoietin-1 (Ang-1) plays a crucial role in vascular and hematopoietic development, mainly through its cognate receptor, Tie-2. Increased levels of Ang-2 have been shown to be correlated with abnormal tumor angiogenesis in several malignancies. Hence, we estimated the increased expression of Ang-2 relative to Ang-1 in patients with colorectal cancer and correlated our finding with prognosis in order to investigate the relationships between the expressions of Ang-1/Ang-2/Tie-2 receptor and the clinical parameters or overall survival of such patients.

Methods

We retrospectively analyzed 114 tissue samples from patients with colorectal cancer by using immunohistochemistry (IHC) to examine Ang-1, Ang-2, and Tie-2 expressions and to investigate the relationship between those expressions and clinical parameters or overall survival of such patients. A Western blot analysis was used for Ang-2 expression.

Results

IHC staining showed a link between Ang-1 and Tie-2 (P = 0.018), as well as meaningful correlations between Ang-2 and Tie-2 receptor (P = 0.022) and between lymph-node metastasis and Ang-2 (P = 0.025). The stronger the IHC staining for Ang-2 expression was, the shorter the cumulative survival was (P = 0.016).

Conclusion

A relationship was found to exist between Ang-2 and Tie-2 expressions. The Ang-2 was correlated with lymph-node metastasis, and high expression of Ang-2 was indicative of poor overall survival. These findings suggest that Ang-2 is a useful prognostic marker in the management of patients with colorectal cancer. In addition, we suggest that Ang/Tie-2 signaling plays an important role in the progression of colorectal cancer.

Citations

Citations to this article as recorded by  
  • The Impact of the Renin-Angiotensin System on the Development of Chronic Obstructive Pulmonary Disease
    森 曹
    Advances in Clinical Medicine.2025; 15(01): 1396.     CrossRef
  • The BMI1-Angiopoietin-2 axis as an independent prognostic factor in colorectal cancer
    Yin-Chou Hsu, Chi-Wen Luo, Shu-Jyuan Chang, Chiao-Ying Lai, Yu-Tzu Yang, Yi-Zi Chen, Mei-Hsiang Hsu, Cheuk-Kwan Sun, Mei-Ren Pan
    Experimental Cell Research.2025; 450(1): 114622.     CrossRef
  • Putative Role of Tie2-Expressing Monocytes/Macrophages in Colorectal Cancer Progression Through Enhancement of Angiogenesis and Metastasis
    Eman Amin M. Ali, Alaa Muayad Altaie, Iman M. Talaat, Rifat Hamoudi
    Cancers.2025; 17(17): 2856.     CrossRef
  • Differential expression of angiogenesis-related genes ‘VEGF’ and ‘angiopoietin-1’ in metastatic and EMAST-positive colorectal cancer patients
    Amir Torshizi Esfahani, Somayeh Mohammadpour, Pooya Jalali, Alireza Yaghoobi, Raana Karimpour, Soha Torkamani, Ali Pardakhtchi, Zahra Salehi, Ehsan Nazemalhosseini-Mojarad
    Scientific Reports.2024;[Epub]     CrossRef
  • Platelet Angiopoietin-1 Protects Against Murine Models of Tumor Metastasis
    Harvey G. Roweth, Isabelle C. Becker, Michael W. Malloy, Emily M. Clarke, Sophie A. Munn, Priya L. Kumar, Ivan Aivasovsky, Kobe Tray, Alec A. Schmaier, Elisabeth M. Battinelli
    Arteriosclerosis, Thrombosis, and Vascular Biology.2024; 44(9): 2024.     CrossRef
  • KRAS mutation-driven angiopoietin 2 bestows anti-VEGF resistance in epithelial carcinomas
    Kayoko Hosaka, Patrik Andersson, Jieyu Wu, Xingkang He, Qiqiao Du, Xu Jing, Takahiro Seki, Juan Gao, Yin Zhang, Xiaoting Sun, Ping Huang, Yunlong Yang, Minghua Ge, Yihai Cao
    Proceedings of the National Academy of Sciences.2023;[Epub]     CrossRef
  • Angiopoietin-2 as a Prognostic Factor in Patients with Incurable Stage IV Colorectal Cancer
    Shinya Munakata, Takae Ueyama, Haruna Ishihara, Hiromitsu Komiyama, Ryoichi Tsukamoto, Masaya Kawai, Makoto Takahashi, Yutaka Kojima, Yuichi Tomiki, Kazuhiro Sakamoto
    Journal of Gastrointestinal Cancer.2021; 52(1): 237.     CrossRef
  • Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study
    Jennifer Mooi, Fiona Chionh, Peter Savas, Jessica Da Gama Duarte, Geoffrey Chong, Stephen Brown, Rachel Wong, Timothy J. Price, Alysson Wann, Effie Skrinos, John M. Mariadason, Niall C. Tebbutt
    Clinical Cancer Research.2021; 27(8): 2159.     CrossRef
  • 6-Gingerol delays tumorigenesis in benzo[a]pyrene and dextran sulphate sodium-induced colorectal cancer in mice
    Ebenezer O. Farombi, Babajide O. Ajayi, Isaac A. Adedara
    Food and Chemical Toxicology.2020; 142: 111483.     CrossRef
  • High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer
    Minna Sopo, Hanna Sallinen, Kirsi Hämäläinen, Annukka Kivelä, Seppo Ylä-Herttuala, Veli-Matti Kosma, Leea Keski-Nisula, Maarit Anttila, Elizabeth Christie
    PLOS ONE.2020; 15(11): e0241484.     CrossRef
  • Evaluation of plasma angiopoietin‐2 and vascular endothelial growth factor in healthy dogs and dogs with systemic inflammatory response syndrome or sepsis
    Maya König, Alice Nentwig, Eliane Marti, Jelena Mirkovitch, Katja‐Nicole Adamik, Simone Schuller
    Journal of Veterinary Internal Medicine.2019; 33(2): 569.     CrossRef
  • Targeting Receptor Kinases in Colorectal Cancer
    Marilina García-Aranda, Maximino Redondo
    Cancers.2019; 11(4): 433.     CrossRef
  • Gene expression and promoter methylation of angiogenic and lymphangiogenic factors as prognostic markers in melanoma
    Ana Carolina Monteiro, Julienne K. Muenzner, Fernando Andrade, Flávia Eichemberger Rius, Christian Ostalecki, Carol I. Geppert, Abbas Agaimy, Arndt Hartmann, André Fujita, Regine Schneider‐Stock, Miriam Galvonas Jasiulionis
    Molecular Oncology.2019; 13(6): 1433.     CrossRef
  • “Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer
    Adriano Angelucci, Simona Delle Monache, Alessio Cortellini, Monica Di Padova, Corrado Ficorella
    International Journal of Molecular Sciences.2018; 19(1): 299.     CrossRef
  • Angiopoietin-2 (Ang-2) is a useful serum tumor marker for liver cancer in the Chinese population
    Yuxin Chen, Yanping Wu, Xiao Zhang, Hong Zeng, Ya Liu, Qi Wu, Yan Chen, GuoQing Zhu, Qiuhui Pan, Lei Jin, Lin Guo, Fenyong Sun
    Clinica Chimica Acta.2018; 478: 18.     CrossRef
  • Efforts to Find Targets Involving Angiogenesis: Step to Improve the Efficacy of Target Therapy in the Era of Colorectal Cancer Treatment
    In Ja Park
    Annals of Coloproctology.2017; 33(1): 1.     CrossRef
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP